Jeevan Scientific Technology Limited (BOM:538837)
India · Delayed Price · Currency is INR 78.60
-1.09 (-1.37%)
At close: Jun 16, 2026
BOM:538837 Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Operating Revenue | 615.37 | 468.44 | 396.5 | 361.78 | 677.93 |
Other Revenue | - | - | 0 | - | 7.4 |
| 615.37 | 468.44 | 396.51 | 361.78 | 685.33 | |
Revenue Growth (YoY) | 31.37% | 18.14% | 9.60% | -47.21% | 44.33% |
Cost of Revenue | 48.77 | 44.9 | 48.21 | 40.73 | 83.71 |
Gross Profit | 566.6 | 423.54 | 348.3 | 321.05 | 601.61 |
Selling, General & Admin | 216.44 | 173.17 | 158.61 | 154.85 | 225.09 |
Amortization of Goodwill & Intangibles | - | 14.74 | 16.78 | 13.85 | - |
Other Operating Expenses | 252 | 175.85 | 143.5 | 152.5 | 192.04 |
Operating Expenses | 534.86 | 411.54 | 361.4 | 358.08 | 454.02 |
Operating Income | 31.74 | 12.01 | -13.1 | -37.03 | 147.59 |
Interest Expense | -20.39 | -17.67 | -9.68 | -10.18 | -9.13 |
Interest & Investment Income | - | 5.12 | 5.46 | 9.84 | 1.48 |
Earnings From Equity Investments | -0.15 | - | - | - | - |
Currency Exchange Gain (Loss) | - | -0.24 | 0.28 | 0.29 | -0.25 |
Other Non Operating Income (Expenses) | 9.73 | 0.17 | 1.01 | 0.26 | 0.25 |
EBT Excluding Unusual Items | 20.92 | -0.6 | -16.04 | -36.83 | 139.95 |
Gain (Loss) on Sale of Investments | - | - | - | - | 40.42 |
Gain (Loss) on Sale of Assets | - | 0.08 | - | - | -0.09 |
Pretax Income | 20.92 | 0.51 | -16.04 | -36.83 | 180.28 |
Income Tax Expense | 10.59 | -0.08 | -2.77 | -6.18 | 60.85 |
Earnings From Continuing Operations | 10.33 | 0.59 | -13.27 | -30.65 | 119.44 |
Minority Interest in Earnings | 1.18 | 0.75 | 0.31 | 0.16 | - |
Net Income | 11.51 | 1.34 | -12.96 | -30.49 | 119.44 |
Net Income to Common | 11.51 | 1.34 | -12.96 | -30.49 | 119.44 |
Net Income Growth | 756.89% | - | - | - | 1.73% |
Shares Outstanding (Basic) | 22 | 16 | 15 | 15 | 15 |
Shares Outstanding (Diluted) | 22 | 16 | 15 | 15 | 15 |
Shares Change (YoY) | 39.77% | 2.28% | 1.00% | 0.16% | 0.00% |
EPS (Basic) | 0.52 | 0.08 | -0.84 | -1.99 | 7.81 |
EPS (Diluted) | 0.52 | 0.08 | -0.84 | -1.99 | 7.81 |
EPS Growth | 513.08% | - | - | - | 1.73% |
Free Cash Flow | -77.64 | -59.59 | -91.37 | -145.68 | 172.19 |
Free Cash Flow Per Share | -3.51 | -3.76 | -5.90 | -9.51 | 11.25 |
Dividend Per Share | - | - | - | - | 1.200 |
Dividend Growth | - | - | - | - | 140.00% |
Gross Margin | 92.07% | 90.42% | 87.84% | 88.74% | 87.78% |
Operating Margin | 5.16% | 2.56% | -3.31% | -10.24% | 21.54% |
Profit Margin | 1.87% | 0.29% | -3.27% | -8.43% | 17.43% |
Free Cash Flow Margin | -12.62% | -12.72% | -23.04% | -40.27% | 25.12% |
EBITDA | 98.17 | 59.05 | 31.15 | 1.88 | 184.38 |
EBITDA Margin | 15.95% | 12.61% | 7.85% | 0.52% | 26.90% |
D&A For EBITDA | 66.42 | 47.05 | 44.25 | 38.91 | 36.79 |
EBIT | 31.74 | 12.01 | -13.1 | -37.03 | 147.59 |
EBIT Margin | 5.16% | 2.56% | -3.31% | -10.24% | 21.54% |
Effective Tax Rate | 50.61% | - | - | - | 33.75% |
Revenue as Reported | 625.1 | 474.96 | 403.25 | 372.52 | 737.18 |
Advertising Expenses | - | 2.35 | 2.79 | 2.25 | 1.59 |